Multiparticulate drug delivery system of aceclofenac: Development and in vitro studies

Drug Development and Industrial Pharmacy

Volumn 35, Issue 2, 2009, Pages 252-258

  Shavi, Gopal Venktesh ^a   Nayak, Usha ^a   Averineni, Ranjith Kumar ^a   Arumugam, Karthik ^a   Meka, Srinivasa Reddy ^a   Nayanabhirama, Udupa ^a   Sureshwar, Pandey ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Aceclofenac; Enteric coated pellets; Eudragit L100 55; Multiparticles; NSAID

Indexed keywords

ACECLOFENAC; EUDRAGIT;

APPARATUS; ARTICLE; CONTROLLED STUDY; DISSOLUTION; DRUG COMPARISON; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG RELEASE; GASTROINTESTINAL TRACT; IN VITRO STUDY; MORPHOLOGY; PARTICLE SIZE; PH; SPHERONIZATION;

ACRYLIC RESINS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; DICLOFENAC; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; TABLETS, ENTERIC-COATED; TECHNOLOGY, PHARMACEUTICAL;

EID: 60749108368     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802277680     Document Type: Article

References (19)

1. Aabakken, L., Olaussen, B., Mowinckel, P., & Osnes, M. (1992). Gastro-duodenal lesions associated with two different piroxicam formulations. An endoscopic evaluation. Scand. J. Gastroenterol., 27, 1049-1054.
2. Alvarez, L., Concheiro, A., Gómez-Amoza, J. L. Souto, C., & Martínez-Pacheco, R. (2002). Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization. Drug Dev. Ind. Pharm., 28, 451-456.
3. Aulton, M. E. (1990). Pharmaceutics: the Science of dosage form design (vol. 1, 2 ed.) London: Churchill Livingstone.
4. Bando, H., & McGinity, J. W. (2006). Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit® S100:L100 dispersion. Int. J. Pharm., 323, 11-17.
5. Bashaiwoldu, F., Abraham, B., & Podczeck, J. M. N. (2004). The application of non-contact laser profilometry to the determination of permanent structural change induced by compaction of pellets II. Pellets dried by different techniques. Eur. J. Pharm. Sci., 22, 55-61.
6. Chopra, R., Podczeck, F., Newton, J. M., & Alderborn, G. (2002). The influence of pellet shape and film coating on the filling of pellets hard shell capsules. Eur. J. Pharm. Biopharm., 53, 327-333.
7. Debunne, A., Vervaet, C., Mangelings, D., & Remon, J. (2004). Compaction of enteric-coated pellets: Influence of formulation and process parameters on tablet properties and in vivo evaluation. Eur. J. Pharm. Sci., 22, 305-314.
8. Hu, L., Liu, Y., Tang, X., & Zhan, Q. (2006). Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets. Eur. J. Pharm. Biopharm., 64, 185-192.
9. Huyghebaert, N., Vermeire, A., Rottiers, P., Remaut, E., & Remon, J. P. (2005). Development of an enteric-coated, layered multi-particulate formulation for ileal delivery of viable recombinant Lactococcus lactis. Eur. J. Pharm. Biopharm., 61, 134-141.
10. Lin, A. Y., & Larry, L. (2001). Augsburger. AAPS Pharm. Sci., 3(2), 1-12.
11. Muatlik, S., Usha, A. N., Reddy, M. S., Ranjith, A. K., & Pandey, S. (2007). Improved bioavailability of aceclofenac from spherical agglomerates: Development, in vitro and preclinical studies. Pak. J. Pharm. Sci., 20(3), 218-226.
12. Mutalik, S., Anju, P., Manoj, K., & Usha, A. N. (2008). Enhancement of dissolution rate and bioavailability of aceclofenac: A chitosan-based solvent change approach. Int. J. Pharm., 350 (1-2), 279-290.
13. Pareek, A., Chandanwale, A. S., Oak, J., Jain, U. K., & Kapoor, S. (2006). Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac - an indian experience. Curr. Med. Res. Opin., 22(5), 977-988.
14. Paulsson, M., & Singh, S. K. (1999). Colloidal and thermal characteristics of concentrated dispersions of polymethacrylate-based latices for aqueous enteric coating. J. Pharm. Sci., 88(4), 406-411.
15. Rahman, N. U., & Yuen, K. H. (2005). Eudragit NE40-drug mixed coating system for controlling drug release of core pellets. Drug Dev. Ind. Pharm., 31, 339-347.
16. Rodriguez, E. C., Torrado, J. J., Nikoakakis, I., Torrado, S., Lastres, J. L., & Malamataris, S. (2001). Micromeritic and packing properties of diclofenac pellets and effets of some formulation varibles. Drug. Dev. Ind. Pharm., 27(8), 847-855.
17. Shivakumar, H. N., Sarasija, S., & Desai, B. G. (2006). Design and evaluation of pH sensitive multi-particulate systems for chronotherapeutic delivery of diltiazem hydrochloride. Indian J. Pharm. Sci., 68(6), 781-787.
18. Sriamornsak, P., Nunthanid, J., Luangtana-anan, M., & Puttipipatkhachorn, S. (2007). Alginate-based pellets prepared by extrusion/spheronization: A preliminary study on the effect of additive in granulating liquid. Eur. J. Pharm. Biopharm., 67, 227-235.
19. Zheng, W., & McGinity, J. W. (2003). Influence of eudragit NE 30 d blended with eudragit- l 30 D-55 on the release of phenylpropanolamine hydrochloride from coated pellets. Drug Dev. Ind. Pharm., 29(3), 357-366.